Valtech Cardio (Israel) a development-stage medical device company focused on minimally invasive percutaneous annuloplasty ring valve repair for the treatment of mitral valve regurgitation, closed a $17.8M Series B financing. Participants include OXO Capital, NGN Capital and Peregrine Ventures.

CicuLite (Saddle Brook, NJ) a clinical-stage medical device company focused on minimally invasive implantable devices for chronic heart failure, closed a $32.5M Series C financing. Participants include Forbion Capital Partners, Crédit Agricole Private Equity, Foundation Medical Partners and Oxford Bioscience Partners.

Direct Flow Medical (Santa Rosa, CA) a development-stage medical device company focused on a percutaneous aortic tissue valve prosthesis, closed a $40M Series C financing. Participants include Johnson & Johnson Development Corp., Foundation Medical Partners, VantagePoint Venture Partners, ePlanet Ventures, EDF Ventures, New Leaf Venture Partners and Spray Venture Partners.

Endosense (Switzerland) a commercial-stage medical device company focused on catheter ablation for the treatment of cardiac arrhythmias, closed a $36M Series B financing. Participants include Edmond de Rothschild Investment Partners, Neomed, Gimv, VI Partners, Sectoral Asset Management, Ysios Capital and Initiative Capital Romandie.

Embrella Cardiovascular (Malvern, PA) an early-stage medical device company focused on cerebral embolic protection during cardiovascular procedures, closed a $1.6M Series B bring the total financing to $6.7M. Participants include BioStarVentures, Edwards Lifesciences and MedFocus Fund.

Coherex Medical (Salt Lake City, UT) a development-stage medical device company focused on the Flatstent™ EF PFO Closure System used to close patent foramen ovale heart defects, closed a $16.5M Series B financing. Participants include Oxford Bioscience Partners, vSpring Capital and Tullis Health Investors.

CardioMEMS (Atlanta, GA) a commercial-stage medical device company with an approved endovascular abdominal aortic aneurysm pressure management system and clinical-stage wireless sensing device for management of cardiovascular diseases such as aneurysms, heart failure and hypertension, closed a $22.1M Series F financing. Participants may have included Arcapita Ventures, Boston Millennia Partners, Medtronic, Easton Capital Partners, [...]

XDx (Brisbane, CA) a commercial-stage molecular diagnostics company focused on noninvasive gene expression tests for the monitoring of immune-mediated conditions, closed a $14.4M Series G financing. Participants include Bristol Myers Squibb (NYSE: BMY), Burrill Venture Capital, DAG Ventures, Integral Capital Partners, Integral Capital Partners, Kleiner Perkins Caulfield & Byers, New Leaf Venture Partners and TPG [...]

Cardiorobotics (Pittsburgh, PA) a clinical-stage medical device company developing cardioArm robot technologies for use in minimally invasive cardiac interventions, closed a $16M Series A financing. Participants include Eagle Ventures, Pittsburgh Life Sciences Greenhouse and the Slater Technology Fund.

Symetis (Switzerland) a clinical-stage medical device company focused on percutaneous valve replacements, closed a $21.2M Series B financing. Participants include Wellington Partners, Vinci Capital–Renaissance, Banexi Venture Partners, Truffle Capital, Novartis Venture Fund, Aravis Venture and BioMedInvest.